{"entity":{"type":"insider","cik":"0001274071","url":"/insider/0001274071","json_url":"/insider/0001274071.json","name":"MURDOCK TERRY L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":12,"first":"2018-08-06","last":"2024-07-08","span_basis":"filed_date"},"name_variants":[{"name":"MURDOCK TERRY L","source":"filing","n_filings":12,"first_seen":"2018-08-06","last_seen":"2024-07-08"}],"transactions":[{"id":2560673,"accession":"0001562180-24-005659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-005659","line_url":"/filing/0001562180-24-005659#line-1","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2475.0,"shares_display":"2,475","price_per_share":2.5077,"price_display":"2.51","price_state":"stated","total_value":6206.5575,"total_display":"6,206.56","total_whole":"6,207","shares_owned_after":128012.0,"shares_owned_after_display":"128,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-08","scope":"insider"},{"id":2402259,"accession":"0001562180-24-004062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-004062","line_url":"/filing/0001562180-24-004062#line-1","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8151.0,"shares_display":"8,151","price_per_share":4.7888,"price_display":"4.79","price_state":"stated","total_value":39033.5088,"total_display":"39,033.51","total_whole":"39,034","shares_owned_after":95487.0,"shares_owned_after_display":"95,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":2056436,"accession":"0001562180-24-000322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-24-000322","line_url":"/filing/0001562180-24-000322#line-4","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":721.0,"shares_display":"721","price_per_share":2.9423,"price_display":"2.94","price_state":"stated","total_value":2121.3983,"total_display":"2,121.40","total_whole":"2,121","shares_owned_after":103638.0,"shares_owned_after_display":"103,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-08","scope":"insider"},{"id":2056433,"accession":"0001562180-24-000322","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-000322","line_url":"/filing/0001562180-24-000322","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3019.0,"shares_display":"3,019","price_per_share":3.1189,"price_display":"3.12","price_state":"stated","total_value":9415.9591,"total_display":"9,415.96","total_whole":"9,416","shares_owned_after":104359.0,"shares_owned_after_display":"104,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-08","scope":"insider","n_lines":2},{"id":8021832,"accession":"0001562180-23-005816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-005816","line_url":"/filing/0001562180-23-005816#line-1","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1361.0,"shares_display":"1,361","price_per_share":2.4537,"price_display":"2.45","price_state":"stated","total_value":3339.4857,"total_display":"3,339.49","total_whole":"3,339","shares_owned_after":70078.0,"shares_owned_after_display":"70,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-07","scope":"insider"},{"id":8615360,"accession":"0001562180-23-000254","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-000254","line_url":"/filing/0001562180-23-000254#line-3","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":5.4075,"price_display":"5.41","price_state":"stated","total_value":3942.0675,"total_display":"3,942.07","total_whole":"3,942","shares_owned_after":36439.0,"shares_owned_after_display":"36,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-05","scope":"insider"},{"id":8615359,"accession":"0001562180-23-000254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-000254","line_url":"/filing/0001562180-23-000254#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1639.0,"shares_display":"1,639","price_per_share":5.5756,"price_display":"5.58","price_state":"stated","total_value":9138.4084,"total_display":"9,138.41","total_whole":"9,138","shares_owned_after":37168.0,"shares_owned_after_display":"37,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6433060,"accession":"0001562180-22-005556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-005556","line_url":"/filing/0001562180-22-005556#line-1","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":5.1715,"price_display":"5.17","price_state":"stated","total_value":3351.132,"total_display":"3,351.13","total_whole":"3,351","shares_owned_after":20907.0,"shares_owned_after_display":"20,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-06","scope":"insider"},{"id":6950795,"accession":"0001562180-22-000307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-000307","line_url":"/filing/0001562180-22-000307#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1445.0,"shares_display":"1,445","price_per_share":10.6115,"price_display":"10.61","price_state":"stated","total_value":15333.6175,"total_display":"15,333.62","total_whole":"15,334","shares_owned_after":21555.0,"shares_owned_after_display":"21,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-05","scope":"insider"},{"id":6880291,"accession":"0001562180-18-004778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004778","line_url":"/filing/0001562180-18-004778#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (SVP of Development Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Development Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3523.0,"shares_display":"3,523","price_per_share":38.5408,"price_display":"38.54","price_state":"stated","total_value":135779.2384,"total_display":"135,779.24","total_whole":"135,779","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-03","scope":"insider"},{"id":6708472,"accession":"0001562180-18-004454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004454","line_url":"/filing/0001562180-18-004454#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (SVP of Development Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Development Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3519.0,"shares_display":"3,519","price_per_share":41.5256,"price_display":"41.53","price_state":"stated","total_value":146128.5864,"total_display":"146,128.59","total_whole":"146,129","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-07","scope":"insider"},{"id":6504996,"accession":"0001562180-18-004187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004187","line_url":"/filing/0001562180-18-004187#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (SVP of Development Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Development Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3519.0,"shares_display":"3,519","price_per_share":49.18,"price_display":"49.18","price_state":"stated","total_value":173064.42,"total_display":"173,064.42","total_whole":"173,064","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-05","scope":"insider"},{"id":5988470,"accession":"0001562180-18-003852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-003852","line_url":"/filing/0001562180-18-003852#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (SVP of Development Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Development Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3519.0,"shares_display":"3,519","price_per_share":59.9786,"price_display":"59.98","price_state":"stated","total_value":211064.6934,"total_display":"211,064.69","total_whole":"211,065","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6166598,"accession":"0001562180-18-003498","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-003498","line_url":"/filing/0001562180-18-003498#line-2","is_derivative":false,"issuer_cik":"0001274071","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001274071","owner_cik":"0001274071","owner_name":"MURDOCK TERRY L","owner_display_name":"MURDOCK TERRY L","owner_url":"/insider/0001274071","role":"Officer (SVP of Development Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Development Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Development Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3519.0,"shares_display":"3,519","price_per_share":50.6,"price_display":"50.60","price_state":"stated","total_value":178061.4,"total_display":"178,061.40","total_whole":"178,061","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-03","filed_date":"2018-08-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Officer (Chief Operating Officer)","n_filings":12,"first_seen":"2018-08-06","last_seen":"2024-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001274071","retrieved_at":"2026-08-26T10:07:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}